peramivir: Clinical Trials

7 trials of peramivir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 withdrawn, 1 terminated. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 4, Withdrawn 2, Terminated 1
Phase 21Completed 1

Follow peramivir: new trials by email Literature Review of peramivir trials Research Report on peramivir

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza
Peramivir - Influenza
Phase 3CompletedBioCryst Pharmaceuticals742015-12-012021-03-23
Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza
Peramivir, Oseltamivir - Influenza
Phase 3CompletedBioCryst Pharmaceuticals1372015-03-112021-03-23
Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections
Peramivir - Influenza
Phase 2 / Phase 3CompletedChinese University of Hong Kong162011-02-012016-01-29
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
Peramivir, Placebo Comparator - Influenza
Phase 3WithdrawnBioCryst Pharmaceuticals2010-10-012026-06-10
Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
Peramivir - Seasonal Influenza, Cough
Phase 3CompletedBioCryst Pharmaceuticals2342009-10-012015-02-12
Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza
Peramivir, Placebo - Influenza
Phase 3TerminatedBioCryst Pharmaceuticals822008-01-012021-03-17
Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
Peramivir 150mg, Peramivir 300mg - Influenza
Phase 3WithdrawnBioCryst Pharmaceuticals2026-06-01

Conditions studied

Influenza, Human (7)  ·  Cough (1)  ·  Fatigue (1)  ·  Headache (1)  ·  Myalgia (1)  ·  Nasal Obstruction (1)  ·  Pharyngitis (1)

Sponsors

BioCryst Pharmaceuticals (6)  ·  Chinese University of Hong Kong (1)

Countries

United States (5)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  Puerto Rico (1)  ·  South Africa (1)

Top investigators

Carol Clark, MD (1)  ·  John Vanchiere, MD, PhD (1)  ·  Nelson Lee (1)

Results publications

PMID 23985625